BNB Plus Corp.

Update in progress

BNBX (OTC Markets OTCQB)

BNB Plus Corp provides digital asset treasury services with real-time data tracking of treasury performance and market indicators. Through its subsidiaries it develops technologies to produce and detect DNA and RNA in the Americas, Europe, Asia, and worldwide. It enzymatically manufactures synthetic DNA for nucleic acid–based therapeutics and supplies production solutions for biopharma and diagnostics, including LineaDNA, LineaRNAP, and LineaIVT, plus a proprietary RNAP for mRNA therapeutics. Formerly Applied DNA Sciences, it changed its name in November 2025. Founded 1983, based in Stony Brook, New York.